(19)
(11) EP 3 528 810 A1

(12)

(43) Date of publication:
28.08.2019 Bulletin 2019/35

(21) Application number: 17862619.8

(22) Date of filing: 19.10.2017
(51) International Patent Classification (IPC): 
A61K 31/47(2006.01)
C07D 217/22(2006.01)
(86) International application number:
PCT/US2017/057439
(87) International publication number:
WO 2018/075796 (26.04.2018 Gazette 2018/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 20.10.2016 US 201662410756 P

(71) Applicant: Celgene Quanticel Research, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • BETANCORT, Juan Manuel
    San Diego California 92129 (US)
  • STAFFORD, Jeffrey Alan
    San Diego California 92130 (US)
  • STANSFIELD, Ryan
    San Diego California 92121 (US)
  • VEAL, James Marvin
    Apex North Carolina 27502 (US)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Dudenstrasse 46
68167 Mannheim
68167 Mannheim (DE)

   


(54) BROMODOMAIN INHIBITOR